Abstract

Alzheimer’s disease (AD) affects an estimated 5.8 million Americans, and advanced age is the greatest risk factor. AD patients have altered intestinal microbiota. Accordingly, depleting intestinal microbiota in AD animal models reduces amyloid-beta (Aβ) plaque deposition. Age-related changes in the microbiota contribute to immunologic and physiologic decline. Translationally relevant dietary manipulations may be an effective approach to slow microbiota changes during aging. We previously showed that calorie restriction (CR) reduced brain Aβ deposition in the well-established Tg2576 mouse model of AD. Presently, we investigated whether CR alters the microbiome during aging. We found that female Tg2576 mice have more substantial age-related microbiome changes compared to wildtype (WT) mice, including an increase in Bacteroides, which were normalized by CR. Specific gut microbiota changes were linked to Aβ levels, with greater effects in females than in males. In the gut, Tg2576 female mice had an enhanced intestinal inflammatory transcriptional profile, which was reversed by CR. Furthermore, we demonstrate that Bacteroides colonization exacerbates Aβ deposition, which may be a mechanism whereby the gut impacts AD pathogenesis. These results suggest that long-term CR may alter the gut environment and prevent the expansion of microbes that contribute to age-related cognitive decline.

Highlights

  • Alzheimer’s disease (AD) affects an estimated 5.8 million Americans, and advanced age is the greatest risk factor

  • We studied the Tg2576 model, where a mutant variant of the human amyloid-beta precursor protein (APP) originally identified in a Swedish family with early-onset AD (APPswe) is expressed in transgenic mice[19,20]

  • This study demonstrates for the first time that female Tg2576 mice show enhancement of age-related microbiota changes compared to WT littermates, and that calorie restriction (CR) reverses age- and Aβ-related changes in the gut microbiota

Read more

Summary

Introduction

Alzheimer’s disease (AD) affects an estimated 5.8 million Americans, and advanced age is the greatest risk factor. Several translational studies show that transferring microbiota from patients with neurodevelopmental and neurological disorders including autism, multiple sclerosis, and Parkinson’s disease can influence behavior, motor dysfunction, and immune responses in relevant animal models[2,3,4,5]. These studies provide evidence that intestinal microbiota may play an etiologic role in diseases that emerge at differing points during the lifespan. This study demonstrates for the first time that female Tg2576 mice show enhancement of age-related microbiota changes compared to WT littermates, and that CR reverses age- and Aβ-related changes in the gut microbiota

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call